With increased regulatory scrutiny, pricing and cost pressures, as well as the rapid developments in genomic technology leading to a more personalised approach to medicine and healthcare, businesses and organisations in the life sciences and healthcare sector face a growing number of complex legal and regulatory challenges in order to stay competitive.
Our International Life Sciences & Healthcare group works with over 50% of the world’s largest pharmaceutical, biotechnology and medical devices companies. We have the largest patent litigation group in Europe and are recognised by major global directories as a top tier life sciences firm.
Our focus on business being changed by technology and the digital world enables us to support our clients operating in this rapidly changing environment. Our multidisciplinary team of 240 specialist life sciences and healthcare lawyers worldwide can advise you on every aspect of the business cycle of a life science and healthcare product or service, from incorporation through development to protection and exploitation of intellectual property.
We can advise you on:
If you would like to know more about how we can help your business, please contact Heads of Group: Marc Martens in Brussels and Mark Hilton in London.
Chambers UK, 2018
Chambers Europe-wide, 2018
Legal 500, 2018
Chambers Asia-Pacific, 2018
Chambers Global- wide, 2018
The UK exits the EU on 31st January 2020. By virtue of the transition period in the Withdrawal Agreement, EU law will continue to apply in and in relation to the UK only until the 31st December 2020
European Medicines Agency (EMA) had communicated to third parties (with some omissions), information contained in toxicological test reports and clinical trial reports obtained in a MA application file on the grounds ...
International law firm Bird & Bird joins 26 organisations in a European Commission funded project that draws on big data to improve the health and wellbeing of European citizens. The four-year project aims to build a ...
International law firm Bird & Bird today announces the merger of its Baseline consulting arm with Valeocon Management Consulting, creating one of the largest management consultancy firms linked to an international law ...
International law firm Bird & Bird has advised Chiesi Farmaceutici S.p.A. ("Chiesi") on the in-licence of Raxone® -- an orphan drug used in the treatment of Leber's hereditary optic neuropathy ("LHON")
We are delighted to invite you to our inaugural Product Design Law Challenge. The Challenge will be based around a series of interactive quiz questions as we take you through the latest developments and trends in design case law, enforcement strategies and filing practices.
Please join us for a practical seminar on English contract law led by Bird & Bird UK partner and contract law specialist, Andrew White.
This seminar, held in English, is intended to provide international businesses operating in Europe with essential know-how and tools on English contract law. It is part of a programme of international client events which have been delivered in eight countries in the last year.
Divergences and Convergences – Identify the key points in local legislations in parallel to the GDPR
Read our latest Brexit update on the implications for the Life Sciences industry https://t.co/JizyoVsn9Z
Transfers of value to “influencers”: new disclosure obligation for companies in the health sector. Read our article… https://t.co/7Et1lOl9qd
Bird & Bird: Setting a gold standard in meeting cannabis regulation with Partner @SallyShorthose and Associate Ben… https://t.co/Ox8Pg4aR9D